198 related articles for article (PubMed ID: 15032655)
1. Current understanding of in-stent restenosis and the potential benefit of drug eluting stents.
Froeschl M; Olsen S; Ma X; O'Brien ER
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Mar; 4(1):103-17. PubMed ID: 15032655
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus-eluting coronary stent.
Vishnevetsky D; Patel P; Tijerino H; Gandhi PJ
Am J Health Syst Pharm; 2004 Mar; 61(5):449-56. PubMed ID: 15018222
[TBL] [Abstract][Full Text] [Related]
3. Perspectives of drug-eluting stents: the next revolution.
Moses JW; Kipshidze N; Leon MB
Am J Cardiovasc Drugs; 2002; 2(3):163-72. PubMed ID: 14727979
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of balloon angioplasty and repeat stenting in patients with drug-eluting in-stent restenosis.
Alfonso F; Sandoval J; Pérez-Vizcayno MJ; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Ibáñez B; Núñez-Gil I; Rivero F; Escaned J; Fernández-Ortíz A; Macaya C
Int J Cardiol; 2015 Jan; 178():213-20. PubMed ID: 25464257
[TBL] [Abstract][Full Text] [Related]
6. Eluting combination drugs from stents.
Thipparaboina R; Khan W; Domb AJ
Int J Pharm; 2013 Sep; 454(1):4-10. PubMed ID: 23850234
[TBL] [Abstract][Full Text] [Related]
7. Overview of therapies for prevention of restenosis after coronary interventions.
Garas SM; Huber P; Scott NA
Pharmacol Ther; 2001; 92(2-3):165-78. PubMed ID: 11916536
[TBL] [Abstract][Full Text] [Related]
8. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
[TBL] [Abstract][Full Text] [Related]
9. The evolution of coronary stents: a brief review.
Simard T; Hibbert B; Ramirez FD; Froeschl M; Chen YX; O'Brien ER
Can J Cardiol; 2014 Jan; 30(1):35-45. PubMed ID: 24286961
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stents: preventing restenosis.
Slavin L; Chhabra A; Tobis JM
Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
[TBL] [Abstract][Full Text] [Related]
11. Prevention of restenosis after coronary angioplasty.
Karthikeyan G; Bhargava B
Curr Opin Cardiol; 2004 Sep; 19(5):500-9. PubMed ID: 15316460
[TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting.
Kiernan TJ; Yan BP; Cruz-Gonzalez I; Cubeddu RJ; Caldera A; Kiernan GD; Gupta V
Cardiovasc Hematol Agents Med Chem; 2008 Apr; 6(2):116-24. PubMed ID: 18473776
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
15. The pathophysiology and burden of restenosis.
Weintraub WS
Am J Cardiol; 2007 Sep; 100(5A):3K-9K. PubMed ID: 17719351
[TBL] [Abstract][Full Text] [Related]
16. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
[TBL] [Abstract][Full Text] [Related]
17. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
[TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
[TBL] [Abstract][Full Text] [Related]
19. The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.
Ambrosini V; Golino L; Niccoli G; Roberto M; Lisanti P; Ceravolo R; Bernardi G; Armigliato P; Gabrielli G; Chizzola G; De Paulis C; Crea F; Colombo A
Cardiovasc Revasc Med; 2017; 18(3):165-168. PubMed ID: 28081977
[TBL] [Abstract][Full Text] [Related]
20. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
